Although further in vitro and in vivo experiments will be needed, AOX1 can be a potential common therapeutic target for SCC treatment, whereas NADK, NNMT, and ENPP1 can be for HNSCC, LuSCC, and CeSCC, respectively. The gene discussed is NADK; the disease is head and neck squamous cell carcinoma.